Notice that Interim Report 3 2022/23 will be published already on March 28, 2023

Phase Holographic Imaging changes the date for publication of Interim Report 3 2022/23 to March 28, 2023.

This decision has been made to provide more time before the start of the upcoming subscription period for the TO3 series warrants.

For additional information, please contact:
Lisa Bodily
E-mail: ir@phiab.com
Web: www.phiab.com – Live cell imaging & analysis

Phase Holographic Imaging (PHI) develops instrumentation and software for time-lapse cytometry. The products are used for long-term quantitative analysis of the dynamics of live cells, particularly significant in the research of cancer, as well as in the treatment of inflammatory and autoimmune diseases. The products are sold globally through the company's distributors. The company is based in Lund, Sweden, and in Boston, Massachusetts.